drugset / Trial / NCT00051259

Effects of Antidepressants on Sexual Functioning

NCT00051259

Phase 3 Completed 420 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to study the effects of two depression medications on sexual functioning.

Timeline

Start
2003-01
Primary completion
2004-06
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Bupropion Small molecule 450 mg